|
1
|
Shackleton M, Quintana E, Fearon ER and
Morrison SJ: Heterogeneity in cancer: cancer stem cells versus
clonal evolution. Cell. 138:822–829. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vermeulen L, Todaro M, de Sousa Mello F,
et al: Single-cell cloning of colon cancer stem cells reveals a
multi-lineage differentiation capacity. Proc Natl Acad Sci USA.
105:13427–13432. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dick JE: Stem cell concepts renew cancer
research. Blood. 112:4793–4807. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Harrison H, Farnie G, Howell SJ, et al:
Regulation of breast cancer stem cell activity by signaling through
the Notch4 receptor. Cancer Res. 70:709–718. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim CF, Jackson EL, Woolfenden AE, et al:
Identification of bronchioalveolar stem cells in normal lung and
lung cancer. Cell. 121:823–835. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Eramo A, Lotti F, Sette G, et al:
Identification and expansion of the tumorigenic lung cancer stem
cell population. Cell Death Differ. 15:504–514. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Seo DC, Sung JM, Cho HJ, et al: Gene
expression profiling of cancer stem cell in human lung
adenocarcinoma A549 cells. Mol Cancer. 6:752007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sullivan JP, Minna JD and Shay JW:
Evidence for self-renewing lung cancer stem cells and their
implications in tumor initiation, progression, and targeted
therapy. Cancer Metastasis Rev. 29:61–72. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maeda R, Yoshida J, Hishida T, et al: Late
recurrence of non-small cell lung cancer more than 5 years after
complete resection: incidence and clinical implications in patient
follow-up. Chest. 138:145–150. 2010.PubMed/NCBI
|
|
14
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar
|
|
15
|
Dylla SJ, Beviglia L, Park IK, et al:
Colorectal cancer stem cells are enriched in xenogeneic tumors
following chemotherapy. PLoS One. 3:e24282008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eramo A, Ricci-Vitiani L, Zeuner A, et al:
Chemotherapy resistance of glioblastoma stem cells. Cell Death
Differ. 13:1238–1241. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tamase A, Muraguchi T, Naka K, et al:
Identification of tumor-initiating cells in a highly aggressive
brain tumor using promoter activity of nucleostemin. Proc Natl Acad
Sci USA. 106:17163–17168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Malanchi I, Peinado H, Kassen D, et al:
Cutaneous cancer stem cell maintenance is dependent on beta-catenin
signalling. Nature. 452:650–653. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Korkaya H, Paulson A, Iovino F and Wicha
MS: HER2 regulates the mammary stem/progenitor cell population
driving tumorigenesis and invasion. Oncogene. 27:6120–6130. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dovey JS, Zacharek SJ, Kim CF and Lees JA:
Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem
cell expansion. Proc Natl Acad Sci USA. 105:11857–11862. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Levina V, Marrangoni AM, DeMarco R,
Gorelik E and Lokshin AE: Drug-selected human lung cancer stem
cells: cytokine network, tumorigenic and metastatic properties.
PLoS One. 3:e30772008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bea S, Tort F, Pinyol M, et al: BMI-1 gene
amplification and overexpression in hematological malignancies
occur mainly in mantle cell lymphomas. Cancer Res. 61:2409–2412.
2001.
|
|
23
|
Tsunoda S, Okumura T, Ito T, et al: ABCG2
expression is an independent unfavorable prognostic factor in
esophageal squamous cell carcinoma. Oncology. 71:251–258. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Donnenberg VS and Donnenberg AD: Multiple
drug resistance in cancer revisited: the cancer stem cell
hypothesis. J Clin Pharmacol. 45:872–877. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tredan O, Galmarini CM, Patel K and
Tannock IF: Drug resistance and the solid tumor microenvironment. J
Natl Cancer Inst. 99:1441–1454. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eyler CE and Rich JN: Survival of the
fittest: cancer stem cells in therapeutic resistance and
angiogenesis. J Clin Oncol. 26:2839–2845. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kanaji N, Bandoh S, Fujita J, Ishii T,
Ishida T and Kubo A: Compensation of type I and type II cytokeratin
pools in lung cancer. Lung Cancer. 55:295–302. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li L and Neaves WB: Normal stem cells and
cancer stem cells: the niche matters. Cancer Res. 66:4553–4557.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Beachy PA, Karhadkar SS and Berman DM:
Tissue repair and stem cell renewal in carcinogenesis. Nature.
432:324–331. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park IK, Morrison SJ and Clarke MF: Bmi1,
stem cells, and senescence regulation. J Clin Invest. 113:175–179.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang HW, Ding J, Jin JL, et al: Defects
in mesenchymal stem cell self-renewal and cell fate determination
lead to an osteopenic phenotype in Bmi-1 null mice. J Bone Miner
Res. 25:640–652. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shakhova O, Leung C and Marino S: Bmi1 in
development and tumorigenesis of the central nervous system. J Mol
Med. 83:596–600. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
van der Lugt NM, Domen J, Linders K, et
al: Posterior transformation, neurological abnormalities, and
severe hematopoietic defects in mice with a targeted deletion of
the bmi-1 proto-oncogene. Genes Dev. 8:757–769. 1994.
|
